By C. Stephen Foster, MD
    AAO 2014

    When it comes to corticosteroid therapy, Dr. Stephen Foster says ophthalmologists should embrace a model of early steroid-sparing, remission-inducing therapy with even more vigor than our colleagues in rheumatology because the eye is so much less forgiving of chronic inflammation than the joint is, with profound life-altering consequences. Dr. Foster provides a detailed model outlining the standard of care for patients with uveitis.